Oct 19 2016 Relmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms View
Sep 28 2016 Relmada Therapeutics' Chief Scientific Officer Dr. Richard Mangano to Speak about d-Methadone as a Potential Rapid Acting Antidepressant at Neuro Advance Boston View
Sep 22 2016 Relmada Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference View
Sep 14 2016 Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern View
Sep 12 2016 Pharmaceutical Industry Leader Ronald M. Burch Joins Relmada Therapeutics Advisory Team View
Sep 07 2016 Relmada Therapeutics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference View
Jun 27 2016 Relmada Therapeutics Announces Notice of Allowance for U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression View
